Escitalopram vs venlafaxine XR treatment of major depressive disorder

被引：0
|
作者：
Montgomery, SA [1 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Dept Psychiat, London, England
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2004年 / 14卷
关键词：
D O I：
10.1016/S0924-977X(04)80166-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S207 / S207
页数：1
相关论文
共 50 条
  • [31] Escitalopram: In the treatment of major depressive disorder in adolescent patients
    Yang L.P.H.
    Scott L.J.
    Pediatric Drugs, 2010, 12 (3) : 155 - 162
  • [32] Comparison of escitalopram and paroxetine in the treatment of major depressive disorder
    Lin, Huang-Li
    Hsu, Ya-Ting
    Liu, Chia-Yih
    Chen, Chia-Hui
    Hsiao, Mei-Chun
    Liu, Yu-Li
    Shen, Winston W.
    Hsiao, Chin-Fu
    Liu, Shen-Ing
    Chang, Liang-Huey
    Tang, Hwa-Sheng
    Lai, Hsiang-Ling
    Lin, Pei-Sheng
    Lin, Keh-Ming
    Tsou, Hsiao-Hui
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2013, 28 (06) : 339 - 345
  • [33] Escitalopram in the treatment of diabetic patients with major depressive disorder
    Pollock, Bruce G.
    Bose, Anjana
    Gordon, John
    Li, Dayong
    Gandhi, Chetan
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S98 - S99
  • [34] Cost-Effectiveness Evaluation in Sweden of Escitalopram Compared with Venlafaxine in Major Depressive Disorder
    Despiegel, Nicolas
    Marteau, Florence
    Danchenko, Natalya
    Linne, Agneta Bjorck
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2009, 12 : S12 - S12
  • [35] Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation
    Llorca, P. M.
    Fernandez, J. -L.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (04) : 702 - 710
  • [36] Cognitive performance in patients with major depressive disorder treated with vortioxetine compared with escitalopram and venlafaxine
    Fernandez-Miranda, J. J.
    Frias-Ortiz, D. F.
    Diaz-Fernandez, S.
    Rubio-Rodriguez, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S794 - S795
  • [37] Pharmacoeconomic analysis of venlafaxine in the treatment of major depressive disorder
    Einarson, TR
    Addis, A
    Iskedjian, M
    PHARMACOECONOMICS, 1997, 12 (02) : 286 - 296
  • [38] Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: A meta-analysis of randomized clinical trials
    Vis, PMJ
    van Baardewijk, M
    Einarson, TR
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (11) : 1798 - 1807
  • [39] A COST-UTILTY ANALYSIS OF VENLAFAXINE XR COMPARED WITH DULOXETINE AND SSRIS FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN ITALY
    Graham, C.
    Narula, H.
    Liu, L. Z.
    Keohane, D.
    Di Virgilio, R.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [40] Treatment of panic disorder with venlafaxine XR
    Ahokas, A
    Bradwejn, J
    Emilien, G
    Whitaker, T
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S377 - S378
12345